Literature DB >> 24047604

Measuring response in the gastrointestinal tract in systemic sclerosis.

Dinesh Khanna1, Vivek Nagaraja, Heather Gladue, William Chey, Mark Pimentel, Tracy Frech.   

Abstract

PURPOSE OF REVIEW: Gastrointestinal tract (GIT) involvement in systemic sclerosis (scleroderma, SSc) is the most common internal complication. This review discusses the outcome measures to capture GIT involvement in clinical care and trials. RECENT
FINDINGS: Patient-reported outcome measures have been validated (UCLA Scleroderma Clinical Trial Consortium GIT 2.0 and NIH PROMIS scales) in SSc-GIT. Multiple objective measures are available to assess mucosal involvement and motility in GIT. However, these need to be validated in SSc for trials.
SUMMARY: GIT is a common cause of morbidity and has negative impact on quality of life in SSc. Recommendations are given for trial design and evaluation of GIT involvement in SSc.

Entities:  

Mesh:

Year:  2013        PMID: 24047604      PMCID: PMC3880116          DOI: 10.1097/01.bor.0000434668.32150.e5

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  61 in total

1.  Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence.

Authors:  T H Rockwood; J M Church; J W Fleshman; R L Kane; C Mavrantonis; A G Thorson; S D Wexner; D Bliss; A C Lowry
Journal:  Dis Colon Rectum       Date:  2000-01       Impact factor: 4.585

2.  Disease-related malnutrition in outpatients with systemic sclerosis.

Authors:  Roberto Caporali; Riccardo Caccialanza; Claudia Bonino; Catherine Klersy; Emanuele Cereda; Blerina Xoxi; Anna Crippa; Maria Luisa Rava; Margherita Orlandi; Chiara Bonardi; Barbara Cameletti; Veronica Codullo; Carlomaurizio Montecucco
Journal:  Clin Nutr       Date:  2012-03-13       Impact factor: 7.324

3.  Nutritional status and gastrointestinal symptoms in systemic sclerosis patients.

Authors:  Maureen A Murtaugh; Tracy M Frech
Journal:  Clin Nutr       Date:  2012-07-04       Impact factor: 7.324

Review 4.  Gastrointestinal complications: the most frequent internal complications of systemic sclerosis.

Authors:  A Forbes; I Marie
Journal:  Rheumatology (Oxford)       Date:  2009-06       Impact factor: 7.580

5.  Validation of the UCLA Scleroderma Clinica Trial Gastrointestinal Tract Instrument version 2.0 for systemic sclerosis.

Authors:  Murray Baron; Marie Hudson; Russell Steele; Ernest Lo
Journal:  J Rheumatol       Date:  2011-07-01       Impact factor: 4.666

6.  Probiotics for the treatment of systemic sclerosis-associated gastrointestinal bloating/ distention.

Authors:  Tracy M Frech; Dinesh Khanna; Paul Maranian; Edward J Frech; Allen D Sawitzke; Maureen A Murtaugh
Journal:  Clin Exp Rheumatol       Date:  2011-05-12       Impact factor: 4.473

7.  FLQAI - A Questionnaire on Quality of Life in Fecal Incontinence: German translation and validation of Rockwood et al.'s (2000) Fecal Incontinence Quality of Life Scale (FIQLS).

Authors:  A Ahnis; M Holzhausen; T H Rockwood; H-P Rosemeier
Journal:  Z Gastroenterol       Date:  2012-07-03       Impact factor: 2.000

8.  Factor structure of the Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire evaluated in patients with heartburn predominant reflux disease.

Authors:  Károly R Kulich; Ingela Wiklund; Ola Junghard
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

9.  Anal resting pressures at manometry correlate with the Fecal Incontinence Severity Index and with presence of sphincter defects on ultrasound.

Authors:  Liliana Bordeianou; Kil Yeon Lee; Todd Rockwood; Nancy N Baxter; Ann Lowry; Anders Mellgren; Susan Parker
Journal:  Dis Colon Rectum       Date:  2008-04-25       Impact factor: 4.585

Review 10.  Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma).

Authors:  H Sallam; T A McNearney; J D Z Chen
Journal:  Aliment Pharmacol Ther       Date:  2006-03-15       Impact factor: 8.171

View more
  25 in total

1.  Sublingual Abnormalities in Systemic Sclerosis.

Authors:  Tracy M Frech; John D Pauling; Maureen A Murtaugh; Katherine Kendall; Robyn T Domsic
Journal:  J Clin Rheumatol       Date:  2016-01       Impact factor: 3.517

Review 2.  [Systemic sclerosis. Current classification and diagnosis of organ involvement].

Authors:  O D Persa; P Moinzadeh; N Hunzelmann
Journal:  Hautarzt       Date:  2015-08       Impact factor: 0.751

3.  The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society.

Authors:  Yaşar Murat Taş; Gözde Derviş Hakim; Pembe Keskinoğlu; Gökçe Kenar; Handan Yarkan; Berrin Zengin; Gerçek Can; Fatoş Önen; Nurullah Akkoç; Merih Birlik; Mesut Akarsu
Journal:  Turk J Gastroenterol       Date:  2019-03       Impact factor: 1.852

Review 4.  Clinical Trial Design Issues in Systemic Sclerosis: an Update.

Authors:  Jessica K Gordon; Robyn T Domsic
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

Review 5.  Gastrointestinal and Hepatic Disease in Systemic Sclerosis.

Authors:  Tracy M Frech; Diane Mar
Journal:  Rheum Dis Clin North Am       Date:  2018-02       Impact factor: 2.670

Review 6.  Intestinal Involvement in Systemic Sclerosis: A Clinical Review.

Authors:  Lazaros I Sakkas; Theodora Simopoulou; Dimitrios Daoussis; Stamatis-Nick Liossis; Spyros Potamianos
Journal:  Dig Dis Sci       Date:  2018-02-21       Impact factor: 3.199

7.  Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales.

Authors:  Brennan M R Spiegel; Ron D Hays; Roger Bolus; Gil Y Melmed; Lin Chang; Cynthia Whitman; Puja P Khanna; Sylvia H Paz; Tonya Hays; Steve Reise; Dinesh Khanna
Journal:  Am J Gastroenterol       Date:  2014-09-09       Impact factor: 10.864

8.  Construct validity of the Patient-Reported Outcomes Measurement Information System gastrointestinal symptom scales in systemic sclerosis.

Authors:  Vivek Nagaraja; Ron D Hays; Puja P Khanna; Brennan M R Spiegel; Lin Chang; Gil Y Melmed; Roger Bolus; Dinesh Khanna
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-11       Impact factor: 4.794

9.  An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups.

Authors:  Murray Baron; Bashar Kahaleh; Elana J Bernstein; Lorinda Chung; Philip J Clements; Christopher Denton; Robyn T Domsic; Nava Ferdowsi; Ivan Foeldvari; Tracy Frech; Jessica K Gordon; Marie Hudson; Sindhu R Johnson; Dinesh Khanna; Zsuzsannah McMahan; Peter A Merkel; Sonali Narain; Mandana Nikpour; John D Pauling; Laura Ross; Antonia Maria Valenzuela Vergara; Alessandra Vacca
Journal:  J Scleroderma Relat Disord       Date:  2018-07-18

Review 10.  A review and roadmap of the skin, lung and gut microbiota in systemic sclerosis.

Authors:  Shannon Teaw; Monique Hinchcliff; Michelle Cheng
Journal:  Rheumatology (Oxford)       Date:  2021-12-01       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.